Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 1

Status

Not yet recruiting 3Active not recruiting 2Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Thoracic 6

Conditions

Carcinoma, Non-Small-Cell Lung 6857Lung Neoplasms 5091Small Cell Lung Carcinoma 1162Breast Neoplasms 854Neoplasms 762Colorectal Neoplasms 664Melanoma 566Ovarian Neoplasms 505Neoplasm Metastasis 480Pancreatic Neoplasms 472Stomach Neoplasms 396Adenocarcinoma of Lung 396Prostatic Neoplasms 369Head and Neck Neoplasms 366Carcinoma, Renal Cell 349Esophageal Neoplasms 336Mesothelioma, Malignant 324Squamous Cell Carcinoma of Head and Neck 323Colonic Neoplasms 293Mesothelioma 289Urinary Bladder Neoplasms 262Brain Neoplasms 253Uterine Cervical Neoplasms 241Triple Negative Breast Neoplasms 220Sarcoma 197Endometrial Neoplasms 195Carcinoma, Hepatocellular 185NSCLC 165Kidney Neoplasms 160Pleural Effusion, Malignant 159

Interventions

Platinum Compounds 2Paclitaxel 2Cisplatin 2Carboplatin 2sintilimab 1osimertinib 1cemiplimab 1Surgical Procedures, Operative 1Pemetrexed 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Resectable Non-small Cell Lung Cancer × Thoracic × Clear all
NCT05247684 2026-03-05

AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC

Akeso

Phase 2 Active not recruiting
90 enrolled
Thoracic

Resectable Non-small Cell Lung Cancer

NCT06161441 2026-01-12

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery

Regeneron Pharmaceuticals

Phase 2 Active not recruiting
195 enrolled
Thoracic

Resectable Non-small Cell Lung Cancer

NCT07038460 2025-06-26

NEO-LISI

Guangdong Provincial People's Hospital

Phase 2 Not yet recruiting
134 enrolled
Thoracic

Resectable Non-small Cell Lung Cancer

NCT06946836 2025-04-27

Neoadjuvant

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Not yet recruiting
80 enrolled
Thoracic

Resectable Non-small Cell Lung Cancer

NCT06485557 2024-07-03

A Prospective Cohort Study of Neoadjuvant Chemotherapy Plus Sintillumab in the Treatment of Resectable NSCLC

Tang-Du Hospital

Phase 3 Not yet recruiting
90 enrolled
Thoracic

Resectable Non-small Cell Lung Cancer

NCT06169956 2024-04-18

NENI

Bristol-Myers Squibb

Recruiting
400 enrolled
Thoracic

Resectable Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡